Evidence to inform decision makers in Thailand: A cost-effectiveness analysis of screening and treatment strategies for postmenopausal osteoporosis

Value in Health

Volumn 15, Issue 1 SUPPL., 2012, Pages

  Kingkaew, Pritaporn ^a   Maleewong, Usawadee ^a,b   Ngarmukos, Chardpraorn ^c   Teerawattananon, Yot ^a  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b MAHASARAKHAM UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

cost utility analysis; decision analysis model; postmenopausal osteoporosis; screening; treatment

Indexed keywords

ALENDRONIC ACID; CALCITONIN; RALOXIFENE; RISEDRONIC ACID;

ADULT; AGED; CLINICAL ASSESSMENT TOOL; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DRUG CHOICE; DUAL ENERGY X RAY ABSORPTIOMETRY; EVIDENCE BASED MEDICINE; FEMALE; FRAGILITY FRACTURE; HEALTH CARE COST; HUMAN; INFORMATION DISSEMINATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; META ANALYSIS (TOPIC); NONBIOLOGICAL MODEL; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; POSTMENOPAUSE OSTEOPOROSIS; PRIMARY PREVENTION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SECONDARY PREVENTION; SELF EVALUATION; SYSTEMATIC REVIEW (TOPIC); THAILAND;

ABSORPTIOMETRY, PHOTON; AGE FACTORS; AGED; AGED, 80 AND OVER; ALENDRONATE; BONE DENSITY CONSERVATION AGENTS; CALCITONIN; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; ETIDRONIC ACID; FEMALE; HUMANS; MARKOV CHAINS; MASS SCREENING; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; RALOXIFENE; THAILAND;

EID: 84856000300     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2011.11.015     Document Type: Conference Paper

References (33)

1. S.R. Cummings, L.J. Melton Epidemiology and outcomes of osteoporotic fractures Lancet 359 2002 1761 1767
2. C.J. Rosen Clinical practice: postmenopausal osteoporosis N Engl J Med 353 2005 595 603
3. K.K. Limpaphayom, N. Taechakraichana, U. Jaisamrarn Prevalence of osteopenia and osteoporosis in Thai women Menopause 8 2001 65 69 (Pubitemid 32066582)
4. E.M. Lau, J.K. Lee, P. Suriwongpaisal The incidence of hip fracture in four Asian countries: the Asian Osteoporosis Study (AOS) Osteoporos Int 12 2001 239 243 (Pubitemid 32288941)
5. J.R. Center, T.V. Nguyen, D. Schneider Mortality after all major types of osteoporotic fracture in men and women: an observational study Lancet 353 1999 878 882 (Pubitemid 29126875)
6. C. Cooper, E.J. Atkinson, S.J. Jacobsen Population-based study of survival after osteoporotic fractures Am J Epidemiol 137 1993 1001 1005 (Pubitemid 23191067)
7. O. Johnell, J.A. Kanis, A. Oden Mortality after osteoporotic fractures Osteoporos Int 15 2004 38 42 (Pubitemid 38252438)
8. World Health Organization Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO Study Group World Health Organ Tech Rep Ser 843 1994 1 129
9. L.K. Koh, W.B. Sedrine, T.P. Torralba A simple tool to identify Asian women at increased risk of osteoporosis Osteoporos Int 12 2001 699 705 (Pubitemid 32889171)
10. S. Panichkul, P. Panichkul, C. Sritara Cost-effectiveness analysis of various screening methods for osteoporosis in perimenopausal Thai women Gynecol Obstet Invest 62 2006 89 96 (Pubitemid 44200487)
11. P. Werayingyong Health Resource Utilization of Osteoporosis Patients at Phramongkutklao Hospital MSc Thesis, Mahidol University, Bangkok 2006
12. T. Jirawattanapisal, P. Kingkaew, T.J. Lee Evidence-based decision-making in Asia-Pacific with rapidly changing health-care systems: Thailand, South Korea, and Taiwan Value Health 12 Suppl. 3 2009 S4 S11
13. Thai Health Technology Assessment Guideline Working Group Thai Health Technology Assessment Guideline 2008 Chulalongkorn University Press Bangkok, Thailand
14. S. van Helden, J. Cals, F. Kessels Risk of new clinical fractures within 2 years following a fracture Osteoporos Int 17 2006 348 354
15. B. Rud, J. Hilden, L. Hyldstrup Performance of the Osteoporosis Self-Assessment Tool in ruling out low bone mineral density in postmenopausal women: a systematic review Osteoporos Int 18 2007 1177 1187 (Pubitemid 47300269)
16. Drug Medical Supply Information Center (DMSIC) Reference price database http://dmsic.moph.go.th/price.htm [Accessed May 20, 2007]
17. A.N. Tosteson, S.E. Gabriel, M.R. Grove Impact of hip and vertebral fractures on quality-adjusted life years Osteoporos Int 12 2001 1042 1049 (Pubitemid 34105976)
18. M. Hiligsmann, O. Ethgen, F. Richy Utility values associated with osteoporotic fracture: a systematic review of the literature Calcif Tissue Int 82 2008 288 292
19. K. Bundhamcharoen, Y. Teerawatananon, T. Vos The Thai Working Group on Burden of Disease and Injuries Burden of Disease and Injuries in Thailand: Priority Setting for Policy 2002 Ministry of Public Health Nonthaburi, Thailand
20. J.A. Kanis, O. Johnell, A. Oden Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds Osteoporos Int 12 2001 989 995 (Pubitemid 34105967)
21. International Monetary Fund World Economic Outlook Database for October 2007 http://www.imf.org/external/pubs/ft/weo/2007/02/weodata/index.aspx [Accessed December 10, 2007]
22. Ministry of Commerce Report for Consumer Price Index http://www.indexpr. moc.go.th/price-present/cpi/stat/others/indexg-report2.asp?table-name= [Accessed October 18, 2007]
23. A.H. Briggs Handling uncertainty in cost-effectiveness models Pharmacoeconomics 17 2000 479 500 (Pubitemid 30398806)
24. Office of the National Economic and Social Development Board National Income of Thailand 2006 Edition http://www.nesdb.go.th/econSocial/macro/gdp- data/mainaccount.htm [Accessed February 15, 2008]
25. A. Briggs, K. Claxton, M. Sculpher Decision Modelling for Health Economic Evaluation 2006 Oxford University Press Oxford
26. D. Weycker, D. Macarios, J. Edelsberg Compliance with drug therapy for postmenopausal osteoporosis Osteoporos Int 17 2006 1645 1652 (Pubitemid 44477625)
27. H.G. Bone, D. Hosking, J.P. Devogelaer Ten years' experience with alendronate for osteoporosis in postmenopausal women N Engl J Med 350 2004 1189 1199 (Pubitemid 38339363)
28. S.T. Harris, N.B. Watts, H.K. Genant Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial Vertebral Efficacy with Risedronate Therapy (VERT) Study Group JAMA 282 1999 1344 1352 (Pubitemid 29483192)
29. J. Reginster, H.W. Minne, O.H. Sorensen et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis Vertebral Efficacy with Risedronate Therapy (VERT) Study Group Osteoporos Int 11 2000 83 91 (Pubitemid 30099515)
30. M. Thavorncharoensap, S. Natanant, W. Kulpeng Assessing a Societal Value for a Ceiling Threshold in Thailand 2009 Health Intervention and Technology Assessment Program Nonthaburi, Thailand
31. O. Johnell, B. Jonsson, L. Jonsson Cost effectiveness of alendronate (Fosamax) for the treatment of osteoporosis and prevention of fractures Pharmacoeconomics 21 2003 305 314 (Pubitemid 36403435)
32. L.R. Mobley, T.J. Hoerger, J.S. Wittenborn Cost-effectiveness of osteoporosis screening and treatment with hormone replacement therapy, raloxifene, or alendronate Med Decis Making 26 2006 194 206
33. S.R. Cummings, S. Eckert, K.A. Krueger The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial Multiple Outcomes of Raloxifene Evaluation JAMA 281 1999 2189 2197 (Pubitemid 29275701)